Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Expert Opinion on Therapeutic Patents|October 7, 2014
cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseasesAna Martinez, Carmen Gil
Current Opinion in Chemical Biology|June 9, 2004
Traceless and multifunctional linkers for the generation of small molecules on solid supportsCarmen Gil, Stefan Bräse
Bioorganic & Medicinal Chemistry|June 12, 2002
The recent impact of solid-phase synthesis on medicinally relevant benzoannelated nitrogen heterocyclesStefan Bräse, Carmen Gil, Kerstin Knepper
European Journal of Medicinal Chemistry|June 1, 2026
From fragments to drugs: How AI and in silico methods accelerate fragment-to-lead optimizationElnaz Aledavood, Jannis Born, Carmen Gil
International Journal of Alzheimer'S Disease|July 16, 2011
Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatmentAna Martinez, Carmen Gil, Daniel I Perez
Medicinal Research Reviews|June 26, 2010
Protein kinases CK1 and CK2 as new targets for neurodegenerative diseasesDaniel I Perez, Carmen Gil, Ana Martinez
Current Topics in Medicinal Chemistry|April 27, 2016
Enhancing cAMP Levels as Strategy for the Treatment of Neuropsychiatric DisordersAna M Garcia, Ana Martinez, Carmen Gil
Current Topics in Medicinal Chemistry|August 13, 2013
Lessons learnt from glycogen synthase kinase 3 inhibitors development for Alzheimer's diseaseAna Martinez, Daniel I Perez, Carmen Gil
Pageof 18